CompaniesByCap
ALGS
Aligos Therapeutics Inc. (ALGS)
NASDAQ · Healthcare

Aligos Therapeutics Inc. Shares Outstanding 2020–2025

Aligos Therapeutics Inc. annual/quarterly shares outstanding history and growth rate from 2020 to 2026. Shares outstanding refers to a company's stock currently held by all its shareholders, including institutional investors and company insiders.

  • Aligos Therapeutics Inc. shares outstanding for the quarter ending March 31, 2026 was 0.01 B shs, a 19.44% increase year-over-year.
  • Aligos Therapeutics Inc. annual shares outstanding for 2025 was 0.01 B shs, a 57.79% increase from 2024.
  • Aligos Therapeutics Inc. annual shares outstanding for 2024 was 0.01 B shs, a 144.38% increase from 2023.
  • Aligos Therapeutics Inc. annual shares outstanding for 2023 was 0.00 B shs, a 94.00% decrease from 2022.
  • Aligos Therapeutics Inc. annual shares outstanding for 2022 was 0.04 B shs.
Shares Outstanding
ANNUAL · B SHS
QUARTERLY · B SHS
YEAR-OVER-YEAR GROWTH · %

Aligos Therapeutics Inc. Shares Outstanding — FAQ

Aligos Therapeutics Inc. (ALGS) shares outstanding over the last 6 years — annual and quarterly figures with year-over-year growth and charts.

What is Aligos Therapeutics Inc.'s shares outstanding?

Aligos Therapeutics Inc. (ALGS) reported shares outstanding of 0.01B shares for fiscal 2025.

Where can I see ALGS's shares outstanding history?

The chart and table above show Aligos Therapeutics Inc.'s shares outstanding by year and by quarter, including the growth rate.